Skip to content

Clinical retrospective analysis of cardiotonic oral solution in the treatment of tumours combined with cardiovascular diseases

Clinical retrospective analysis of cardiotonic oral solution in the treatment of tumours combined with cardiovascular diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001973
Enrollment
Unknown
Registered
2025-10-22
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiooncology

Interventions

Xintong Oral Liquid + Western Medicine Group:Does not involve intervention measures.
Other Chinese herbal medicine plus Western medicine group:Does not involve intervention measures.
Western medicine group:Does not involve intervention measures.

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1) No restriction on gender, age =18 years old; 2) Confirmed as malignant tumor through pathology, cytology, radiology, or ultrasound examination; 3) Meets diagnostic criteria for impaired cardiac function (left ventricular ejection fraction is borderline or decreased, abnormal electrocardiogram, BNP/cardiac troponin is borderline or elevated), coronary artery disease, or arrhythmia.

Exclusion criteria

Exclusion criteria: Individuals with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Clinical Efficacy;TCM Syndrome Score;The frequency and duration of angina attacks;

Secondary

MeasureTime frame
Three markers for myocardial infarction (Troponin I (cTnI), Creatine kinase-MB (CK-MB), and Myoglobin (Myo));N-terminal pro-B-type natriuretic peptide (NT-proBNP);Cardiac Color Doppler Examination;24-hour ambulatory electrocardiogram (ECG) monitoring for paroxysmal ventricular tachycardia (PVT) and ventricular premature contractions (PVCs).;

Countries

China

Contacts

Public ContactLI HAIXIA

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

academic_lhx@163.com18611544788

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026